Genomics Bioscience & Technology Co

Genomics Bioscience & Technology Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genomics Bioscience & Technology Co (4195.TWO) as of Oct 9, 2026 is -74.62 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -227.36 M TWD — a change of -67.18% (higher).

EBITDA

-74.62 MTWD

YoY

-67.18%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genomics Bioscience & Technology Co is 2025 -74.62 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genomics Bioscience & Technology Co was 2024 -227.36 M TWD. It decreases by -67.18% higher compared to the previous year.

The Genomics Bioscience & Technology Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-35.22 M TWD
Jan 1, 2019
12.92 M TWD
Jan 1, 2020
2.20 M TWD
Jan 1, 2021
13.65 M TWD
Jan 1, 2022
76.43 M TWD
Jan 1, 2023
-164.81 M TWD
Jan 1, 2024
-227.36 M TWD
Jan 1, 2025
-74.62 M TWD
The Genomics Bioscience & Technology Co EBITDA history
YEAREBITDAYoY
-74.62 MTWD-67.18%
-227.36 MTWD+37.95%
-164.81 MTWD-315.64%
76.43 MTWD+459.99%
13.65 MTWD+520.65%
2.20 MTWD-82.97%
12.92 MTWD-136.68%
-35.22 MTWD-1.37%
-35.70 MTWD-17.38%
-43.21 MTWD+27.08%
-34.00 MTWD-12.00%
-38.64 MTWD—
Access this data via the Eulerpool API
Get Free API Key

Genomics Bioscience & Technology Co Stock analysis

What does Genomics Bioscience & Technology Co do? Genomics Bioscience & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomics Bioscience & Technology Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genomics Bioscience & Technology Co is -74.62 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genomics Bioscience & Technology Co changed from -227.36 M TWD to -74.62 M TWD, representing a -67.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Genomics Bioscience & Technology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Genomics Bioscience & Technology Co historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Genomics Bioscience & Technology Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Genomics Bioscience & Technology Co